SEARCH

SEARCH BY CITATION

References

  • Ageno, W. , Gallus, A.S. , Wittkowsky, A. , Crowther, M. , Hylek, E.M. & Palareti, G. (2012) Oral anticoagulant therapy: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e44Se88S.
  • Anderson, Jr, F.A. , Wheeler, H.B. , Goldberg, R.J. , Hosmer, D.W. , Patwardhan, N.A. , Jovanovic, B. , Forcier, A. & Dalen, J.E. (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Archives of Internal Medicine, 151, 933938.
  • Badaracco, M.A. & Vessey, M.P. (1974) Recurrence of venous thromboembolic disease and use of oral contraceptives. British Medical Journal, 1, 215217.
  • Baglin, T. , Luddington, R. , Brown, K. & Baglin, C. (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet, 362, 523526.
  • Baglin, T. , Douketis, J. , Tosetto, A. , Marcucci, M. , Cushman, M. , Kyrle, P. , Palareti, G. , Poli, D. , Tait, R.C. & Iorio, A. (2010) Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis. Journal of Thrombosis and Haemostasis, 8, 24362442.
  • Baglin, T. , Bauer, K. , Douketis, J. , Buller, H. , Srivastava, A. & Johnson, G. (2012) Duration of anticoagulant therapy after a first episode of unprovoked pulmonary embolus or deep vein thrombosis: guidance from the scientific and standardization committee of the international society on thrombosis and haemostasis. Journal of Thrombosis and Haemostasis, 10, 698702.
  • Bates, S.M. , Greer, I.A. , Middeldorp, S. , Veenstra, D.L. , Prabulos, A.M. & Vandvik, P.O. (2012) VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e691Se736S.
  • Bauersachs, R. , Berkowitz, S.D. , Brenner, B. , Buller, H.R. , Decousus, H. , Gallus, A.S. , Lensing, A.W. , Misselwitz, F. , Prins, M.H. , Raskob, G.E. , Segers, A. , Verhamme, P. , Wells, P. , Agnelli, G. , Bounameaux, H. , Cohen, A. , Davidson, B.L. , Piovella, F. & Schellong, S. (2010) Oral rivaroxaban for symptomatic venous thromboembolism. New England Journal of Medicine, 363, 24992510.
  • Bernstein, C.N. , Blanchard, J.F. , Houston, D.S. & Wajda, A. (2001) The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thrombosis and Haemostasis, 85, 430434.
  • Boutitie, F. , Pinede, L. , Schulman, S. , Agnelli, G. , Raskob, G. , Julian, J. , Hirsh, J. & Kearon, C. (2011) Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials. British Medical Journal, 342, d3036.
  • Brandjes, D.P. , Buller, H.R. , Heijboer, H. , Huisman, M.V. , de, R.M. , Jagt, H. & ten Cate, J.W. (1997) Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet, 349, 759762.
  • Canonico, M. , Plu-Bureau, G. , Lowe, G.D. & Scarabin, P.Y. (2008) Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. British Medical Journal, 336, 12271231.
  • Carrier, M. , Le Gal, G. , Wells, P.S. & Rodger, M.A. (2010) Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Annals of Internal Medicine, 152, 578589.
  • Carrier, M. , Rodger, M.A. , Wells, P.S. , Righini, M. & Le Gal, G. (2011) Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis. Journal of Thrombosis and Haemostasis, 9, 11191125.
  • Christiansen, S.C. , Cannegieter, S.C. , Koster, T. , Vandenbroucke, J.P. & Rosendaal, F.R. (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. Journal of the American Medical Association, 293, 23522361.
  • Connolly, S.J. , Ezekowitz, M.D. , Yusuf, S. , Eikelboom, J. , Oldgren, J. , Parekh, A. , Pogue, J. , Reilly, P.A. , Themeles, E. , Varrone, J. , Wang, S. , Alings, M. , Xavier, D. , Zhu, J. , Diaz, R. , Lewis, B.S. , Darius, H. , Diener, H.C. , Joyner, C.D. & Wallentin, L. (2009) Dabigatran versus warfarin in patients with atrial fibrillation. New England Journal of Medicine, 361, 11391151.
  • Cushman, M. , Glynn, R.J. , Goldhaber, S.Z. , Moll, S. , Bauer, K.A. , Deitcher, S. , Shrivastava, S. & Ridker, P.M. (2006) Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. Journal of Thrombosis and Haemostasis, 4, 21992203.
  • De Stefano, V. , Martinelli, I. , Rossi, E. , Battaglioli, T. , Za, T. , Mannuccio, M.P. & Leone, G. (2006) The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis. British Journal of Haematology, 135, 386391.
  • Donadini, M.P. & Ageno, W. (2011) Which patients with unprovoked VTE should receive extended anticoagulation? the minority. Journal of Thrombosis and Thrombolysis, 31, 301305.
  • van Dongen, C.J. , Vink, R. , Hutten, B.A. , Buller, H.R. & Prins, M.H. (2003) The incidence of recurrent venous thromboembolism after treatment with vitamin K antagonists in relation to time since first event: a meta-analysis. Archives of Internal Medicine, 163, 12851293.
  • Douketis, J.D. , Kearon, C. , Bates, S. , Duku, E.K. & Ginsberg, J.S. (1998) Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. Journal of the American Medical Association, 279, 458462.
  • Douketis, J. , Tosetto, A. , Marcucci, M. , Baglin, T. , Cosmi, B. , Cushman, M. , Kyrle, P. , Poli, D. , Tait, R.C. & Iorio, A. (2011) Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. British Medical Journal, 342, d813.
  • Doyle, D.J. , Turpie, A.G. , Hirsh, J. , Best, C. , Kinch, D. , Levine, M.N. & Gent, M. (1987) Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial. Annals of Internal Medicine, 107, 441445.
  • Farmer, R.D. , Lawrenson, R.A. , Thompson, C.R. , Kennedy, J.G. & Hambleton, I.R. (1997) Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Lancet, 349, 8388.
  • Farraj, R.S. (2004) Anticoagulation period in idiopathic venous thromboembolism. How long is enough? Saudi Medical Journal, 25, 848851.
  • Flinterman, L.E. , van Hylckama Vlieg, A. , Rosendaal, F.R. & Doggen, C.J. (2008) Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity. Circulation, 118, 13661372.
  • Guyatt, G.H. , Norris, S.L. , Schulman, S. , Hirsh, J. , Eckman, M.H. , Akl, E.A. , Crowther, M. , Vandvik, P.O. , Eikelboom, J.W. , McDonagh, M.S. , Lewis, S.Z. , Gutterman, D.D. , Cook, D.J. & Schunemann, H.J. (2012) Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, 53S70S.
  • Hart, R.G. , Benavente, O. & Pearce, L.A. (1999) Increased risk of intracranial hemorrhage when aspirin is combined with warfarin: a meta-analysis and hypothesis. Cerebrovascular Diseases, 9, 215217.
  • Heit, J.A. , Silverstein, M.D. , Mohr, D.N. , Petterson, T.M. , O'Fallon, W.M. & Melton, L.J. III (2000a) Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Archives of Internal Medicine, 160, 809815.
  • Heit, J.A. , Mohr, D.N. , Silverstein, M.D. , Petterson, T.M. , O'Fallon, W.M. & Melton, L.J. III (2000b) Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Archives of Internal Medicine, 160, 761768.
  • Ho, W.K. , Hankey, G.J. , Quinlan, D.J. & Eikelboom, J.W. (2006) Risk of recurrent venous thromboembolism in patients with common thrombophilia: a systematic review. Archives of Internal Medicine, 166, 729736.
  • Huisman, M.V. , Buller, H.R. , ten Cate, J.W. , van Royen, E.A. , Vreeken, J. , Kersten, M.J. & Bakx, B. (1989) Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest, 95, 498502.
  • Hull, R.D. , Hirsh, J. , Carter, C.J. , Jay, R.M. , Dodd, P.E. , Ockelford, P.A. , Coates, G. , Gill, G.J. , Turpie, A.G. , Doyle, D.J. , Buller, H.R. & Raskob, G.E. (1983) Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Annals of Internal Medicine, 98, 891899.
  • Hutten, B.A. & Prins, M.H. (2006) Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism. Cochrane Database of Systematic Reviews, issue 1, Art. No CD001367.
  • Hutten, B.A. , Lensing, A.W. , Kraaijenhagen, R.A. & Prins, M.H. (1999) Safety of treatment with oral anticoagulants in the elderly. A systematic review. Drugs and Aging, 14, 303312.
  • van Hylckama Vlieg, A. & Middeldorp, S. (2011) Hormone therapies and venous thromboembolism: where are we now? Journal of Thrombosis and Haemostasis, 9, 257266.
  • van Hylckama Vlieg, A. , Helmerhorst, F.M. , Vandenbroucke, J.P. , Doggen, C.J. & Rosendaal, F.R. (2009) The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study. British Medical Journal, 339, b2921.
  • Iorio, A. , Kearon, C. , Filippucci, E. , Marcucci, M. , Macura, A. , Pengo, V. , Siragusa, S. & Palareti, G. (2010) Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review. Archives of Internal Medicine, 170, 17101716.
  • Kearon, C. , Gent, M. , Hirsh, J. , Weitz, J. , Kovacs, M.J. , Anderson, D.R. , Turpie, A.G. , Green, D. , Ginsberg, J.S. , Wells, P. , MacKinnon, B. & Julian, J.A. (1999) A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. New England Journal of Medicine, 340, 901907.
  • Kearon, C. , Akl, E.A. , Comerota, A.J. , Prandoni, P. , Bounameaux, H. , Goldhaber, S.Z. , Nelson, M.E. , Wells, P.S. , Gould, M.K. , Dentali, F. , Crowther, M. & Kahn, S.R. (2012) Antithrombotic therapy for VTE disease: antithrombotic Therapy and Prevention of Thrombosis, 9th edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e419Se494S.
  • Kruit, W.H. , de Boer, A.C. , Sing, A.K. & van Roon, F. (1991) The significance of venography in the management of patients with clinically suspected pulmonary embolism. Journal of Internal Medicine, 230, 333339.
  • Kyrle, P.A. , Minar, E. , Bialonczyk, C. , Hirschl, M. , Weltermann, A. & Eichinger, S. (2004) The risk of recurrent venous thromboembolism in men and women. New England Journal of Medicine, 350, 25582563.
  • Le Gal, G. , Kovacs, M.J. , Carrier, M. , Do, K. , Kahn, S.R. , Wells, P.S. , Anderson, D.A. , Chagnon, I. , Solymoss, S. , Crowther, M. , Righini, M. , Lacut, K. , White, R.H. , Vickars, L. & Rodger, M. (2010) Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study. Thrombosis and Haemostasis, 104, 498503.
  • Lee, A.Y. , Levine, M.N. , Baker, R.I. , Bowden, C. , Kakkar, A.K. , Prins, M. , Rickles, F.R. , Julian, J.A. , Haley, S. , Kovacs, M.J. & Gent, M. (2003) Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. New England Journal of Medicine, 349, 146153.
  • Lidegaard, O. , Lokkegaard, E. , Svendsen, A.L. & Agger, C. (2009) Hormonal contraception and risk of venous thromboembolism: national follow-up study. British Medical Journal, 339, b2890.
  • Lijfering, W.M. , Veeger, N.J. , Middeldorp, S. , Hamulyak, K. , Prins, M.H. , Buller, H.R. & Van Der Meer, J. (2009) A lower risk of recurrent venous thrombosis in women compared with men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families. Blood, 114, 20312036.
  • Lim, W. , Crowther, M.A. & Eikelboom, J.W. (2006) Management of antiphospholipid antibody syndrome: a systematic review. Journal of the American Medical Association, 295, 10501057.
  • Linkins, L.A. , Choi, P.T. & Douketis, J.D. (2003) Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Annals of Internal Medicine, 139, 893900.
  • Locadia, M. , Bossuyt, P.M. , Stalmeier, P.F. , Sprangers, M.A. , van Dongen, C.J. , Middeldorp, S. , Bank, I. , Van Der Meer, J. , Hamulyak, K. & Prins, M.H. (2004) Treatment of venous thromboembolism with vitamin K antagonists: patients' health state valuations and treatment preferences. Thrombosis and Haemostasis, 92, 13361341.
  • Martinelli, I. , Battaglioli, T. , Bucciarelli, P. , Passamonti, S.M. & Mannucci, P.M. (2004) Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Circulation, 110, 566570.
  • McRae, S. , Tran, H. , Schulman, S. , Ginsberg, J. & Kearon, C. (2006) Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis. Lancet, 368, 371378.
  • van der Meer, F.J. , Rosendaal, F.R. , Vandenbroucke, J.P. & Briet, E. (1993) Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Archives of Internal Medicine, 153, 15571562.
  • van der Meer, F.J. , Rosendaal, F.R. , Vandenbroucke, J.P. & Briet, E. (1996) Assessment of a bleeding risk index in two cohorts of patients treated with oral anticoagulants. Thrombosis and Haemostasis, 76, 1216.
  • Middeldorp, S. (2011a) Is thrombophilia testing useful? American Society of Hematology Education Program, 2011, 150155.
  • Middeldorp, S. (2011b) Duration of anticoagulation for venous thromboembolism. British Medical Journal, 342, d2758.
  • Miehsler, W. , Reinisch, W. , Valic, E. , Osterode, W. , Tillinger, W. , Feichtenschlager, T. , Grisar, J. , Machold, K. , Scholz, S. , Vogelsang, H. & Novacek, G. (2004) Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut, 53, 542548.
  • Murin, S. , Romano, P.S. & White, R.H. (2002) Comparison of outcomes after hospitalization for deep venous thrombosis or pulmonary embolism. Thrombosis and Haemostasis, 88, 407414.
  • Naess, I.A. , Christiansen, S.C. , Romundstad, P. , Cannegieter, S.C. , Rosendaal, F.R. & Hammerstrom, J. (2007) Incidence and mortality of venous thrombosis: a population-based study. Journal of Thrombosis and Haemostasis, 5, 692699.
  • Novacek, G. , Weltermann, A. , Sobala, A. , Tilg, H. , Petritsch, W. , Reinisch, W. , Mayer, A. , Haas, T. , Kaser, A. , Feichtenschlager, T. , Fuchssteiner, H. , Knoflach, P. , Vogelsang, H. , Miehsler, W. , Platzer, R. , Tillinger, W. , Jaritz, B. , Schmid, A. , Blaha, B. , Dejaco, C. & Eichinger, S. . (2010) Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism. Gastroenterology, 139, 779787.
  • Pabinger, I. , Grafenhofer, H. , Kyrle, P.A. , Quehenberger, P. , Mannhalter, C. , Lechner, K. & Kaider, A. (2002) Temporary increase in the risk for recurrence during pregnancy in women with a history of venous thromboembolism. Blood, 100, 10601062.
  • Pabinger, I. , Grafenhofer, H. , Kaider, A. , Kyrle, P.A. , Quehenberger, P. , Mannhalter, C. & Lechner, K. (2005) Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. Journal of Thrombosis and Haemostasis, 3, 949954.
  • Palareti, G. , Legnani, C. , Cosmi, B. , Guazzaloca, G. , Pancani, C. & Coccheri, S. (2002) Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped. Thrombosis and Haemostasis, 87, 712.
  • Palareti, G. , Cosmi, B. , Legnani, C. , Tosetto, A. , Brusi, C. , Iorio, A. , Pengo, V. , Ghirarduzzi, A. , Pattacini, C. , Testa, S. , Lensing, A.W. & Tripodi, A. (2006) D-dimer testing to determine the duration of anticoagulation therapy. New England Journal of Medicine, 355, 17801789.
  • Patel, M.R. , Mahaffey, K.W. , Garg, J. , Pan, G. , Singer, D.E. , Hacke, W. , Breithardt, G. , Halperin, J.L. , Hankey, G.J. , Piccini, J.P. , Becker, R.C. , Nessel, C.C. , Paolini, J.F. , Berkowitz, S.D. , Fox, K.A. & Califf, R.M. (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. New England Journal of Medicine, 365, 883891.
  • Pomp, E.R. , le Cessie, S. , Rosendaal, F.R. & Doggen, C.J. (2007) Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. British Journal of Haematology, 139, 289296.
  • Pomp, E.R. , Lenselink, A.M. , Rosendaal, F.R. & Doggen, C.J. (2008) Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. Journal of Thrombosis and Haemostasis, 6, 632637.
  • Prandoni, P. , Lensing, A.W. , Cogo, A. , Cuppini, S. , Villalta, S. , Carta, M. , Cattelan, A.M. , Polistena, P. , Bernardi, E. & Prins, M.H. (1996) The long-term clinical course of acute deep venous thrombosis. Annals of Internal Medicine, 125, 17.
  • Prandoni, P. , Lensing, A.W. , Piccioli, A. , Bernardi, E. , Simioni, P. , Girolami, B. , Marchiori, A. , Sabbion, P. , Prins, M.H. , Noventa, F. & Girolami, A. (2002a) Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis. Blood, 100, 34843488.
  • Prandoni, P. , Lensing, A.W. , Prins, M.H. , Bernardi, E. , Marchiori, A. , Bagatella, P. , Frulla, M. , Mosena, L. , Tormene, D. , Piccioli, A. , Simioni, P. & Girolami, A. (2002b) Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Annals of Internal Medicine, 137, 955960.
  • Prandoni, P. , Lensing, A.W. , Prins, M.H. , Frulla, M. , Marchiori, A. , Bernardi, E. , Tormene, D. , Mosena, L. , Pagnan, A. & Girolami, A. (2004) Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial. Annals of Internal Medicine, 141, 249256.
  • Prandoni, P. , Noventa, F. , Ghirarduzzi, A. , Pengo, V. , Bernardi, E. , Pesavento, R. , Iotti, M. , Tormene, D. , Simioni, P. & Pagnan, A. (2007) The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica, 92, 199205.
  • Ridker, P.M. , Goldhaber, S.Z. , Danielson, E. , Rosenberg, Y. , Eby, C.S. , Deitcher, S.R. , Cushman, M. , Moll, S. , Kessler, C.M. , Elliott, C.G. , Paulson, R. , Wong, T. , Bauer, K.A. , Schwartz, B.A. , Miletich, J.P. , Bounameaux, H. & Glynn, R.J. (2003) Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. New England Journal of Medicine, 348, 14251434.
  • Rodger, M.A. , Kahn, S.R. , Wells, P.S. , Anderson, D.A. , Chagnon, I. , Le Gal, G. , Solymoss, S. , Crowther, M. , Perrier, A. , White, R. , Vickars, L. , Ramsay, T. , Betancourt, M.T. & Kovacs, M.J. (2008) Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy. Canadian Medical Association Journal, 179, 417426.
  • Schulman, S. , Granqvist, S. , Holmstrom, M. , Carlsson, A. , Lindmarker, P. , Nicol, P. , Eklund, S.G. , Nordlander, S. , Larfars, G. , Leijd, B. , Linder, O. & Loogna, E. (1997) The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. New England Journal of Medicine, 336, 393398.
  • Schulman, S. , Svenungsson, E. & Granqvist, S. (1998) Anticardiolipin antibodies predict early recurrence of thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy. Duration of Anticoagulation Study Group. American Journal of Medicine, 104, 332338.
  • Schulman, S. , Wahlander, K. , Lundstrom, T. , Clason, S.B. & Eriksson, H. (2003) Secondary prevention of venous thromboembolism with the oral direct thrombin inhibitor ximelagatran. New England Journal of Medicine, 349, 17131721.
  • Schulman, S. , Kearon, C. , Kakkar, A.K. , Mismetti, P. , Schellong, S. , Eriksson, H. , Baanstra, D. , Schnee, J. & Goldhaber, S.Z. (2009) Dabigatran versus warfarin in the treatment of acute venous thromboembolism. New England Journal of Medicine, 361, 23422352.
  • Schulman, S. , Baanstra, D. , Eriksson, H. , Goldhaber, S. , Kakkar, A. , Kearon, C. , Mismetti, P. , Schellong, S. & Schnee, J. (2011) Dabigatran versus placebo for extended maintenance therapy of venous thromboembolism. Journal of Thrombosis and Haemostasis, 9, 1250. O-MO-037.
  • Stain, M. , Schonauer, V. , Minar, E. , Bialonczyk, C. , Hirschl, M. , Weltermann, A. , Kyrle, P.A. & Eichinger, S. (2005) The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease. Journal of Thrombosis and Haemostasis, 3, 26712676.
  • Verhovsek, M. , Douketis, J.D. , Yi, Q. , Shrivastava, S. , Tait, R.C. , Baglin, T. , Poli, D. & Lim, W. (2008) Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Annals of Internal Medicine, 149, 481490, W94.
  • White, R.H. , Chan, W.S. , Zhou, H. & Ginsberg, J.S. (2008) Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism. Thrombosis and Haemostasis, 100, 246252.
  • Zoller, B. , Li, X. , Sundquist, J. & Sundquist, K. (2012) Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet, 379, 244249.